Crescita Therapeutics (TSX:CTX) Long-Term Debt : C$0.00 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Long-Term Debt?

Crescita Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2024 was C$0.00 Mil.

Crescita Therapeutics Long-Term Debt Historical Data

The historical data trend for Crescita Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Long-Term Debt Chart

Crescita Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Debt

Get a 7-Day Free Trial

0.93

Crescita Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Crescita Therapeutics (TSX:CTX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Crescita Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada.

Executives

Jose Darocha	Director, Senior Officer
Daniel Chicoine	Director, Senior Officer
Serge Verreault	Senior Officer
Anthony Edward Dobranowski	Director
Knight Therapeutics Inc.	10% Security Holder

Crescita Therapeutics Headlines

No Headlines